PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30872116-2	2019	LOBP has been attributed to beta2-adrenergic receptor (B2AR) downregulation, a process requiring farnesylation, which is inhibited by alendronate.	Alendronate	134-145	adrenoceptor beta 2	Homo sapiens	28-53	
30872116-2	2019	LOBP has been attributed to beta2-adrenergic receptor (B2AR) downregulation, a process requiring farnesylation, which is inhibited by alendronate.	Alendronate	134-145	adrenoceptor beta 2	Homo sapiens	55-59	
30872116-10	2019	The after/before ICS plus LABA treatment ratio of B2AR number was 1.0 for alendronate (P = .86) and 0.8 for placebo (P = .15; P = .31 for difference between treatments).	Alendronate	74-85	adrenoceptor beta 2	Homo sapiens	50-54	
30872116-11	2019	The B2AR signaling ratio was 0.89 for alendronate (P = .43) and 1.02 for placebo (P = .84; P = .44 for difference).	Alendronate	38-49	adrenoceptor beta 2	Homo sapiens	4-8